Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Guelph
$4,950.00
Signalling mechanisms of the skeletal muscle adaptor protein, ShcD
FY 2011-12
Summary
Signal transduction is a central process in multicellular organisms that allows for the exchange of informational cues between and within cells. These cues are interpreted by organized networks of protein interactions inside the cell which regulate complex biochemical events, ultimately converting them into biological responses such as growth, differentiation and survival. A specialized region of contact between motor neurons and skeletal muscle fibres that controls the transmission of nerve signals to muscles is the neuromuscular junction (NMJ). Defects in neuromuscular transmission at the NMJ underlie a series of disorders associated with fatigable muscle weakness, including congenital myasthenic syndromes and the auto-immune disease myasthenia gravis. In addition to progressive muscle paralysis, the muscles that control swallowing and/or breathing can become weakened, leading to respiratory failure. Understanding the molecular basis of communication between nerves and muscles is therefore of key importance in defining how particular mutations can contribute to such pathological conditions. We have recently identified a novel intracellular signaling protein, ShcD that is expressed in skeletal muscle and participates in signaling pathways that ultimately control muscle contraction. We have now determined that ShcD can associate with additional cell surface receptors that may be important for development and differentiation of muscle cells at the NMJ. Using a combination of biochemical and cellular approaches, we propose to identify the molecular components and biological functions associated with ShcD in skeletal muscle cells and NMJs. The structure of this specialized synapse is under exquisite molecular control; thus, increasing our knowledge of the signaling mechanisms that contribute to the assembly and maintenance of the NMJ will provide further insight into how perturbations arise in diseases with altered neuromuscular transmission.
Department
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
251746
Name
Acai Anita
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Signalling mechanisms of the skeletal muscle adaptor protein, ShcD
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Neuromuscular Junction (Nmj); Neurotrophin Receptors; Signal Transduction; Skeletal Muscle Cells; Tyrosine Phosphorylation
Abstract
Signal transduction is a central process in multicellular organisms that allows for the exchange of informational cues between and within cells. These cues are interpreted by organized networks of protein interactions inside the cell which regulate complex biochemical events, ultimately converting them into biological responses such as growth, differentiation and survival. A specialized region of contact between motor neurons and skeletal muscle fibres that controls the transmission of nerve signals to muscles is the neuromuscular junction (NMJ). Defects in neuromuscular transmission at the NMJ underlie a series of disorders associated with fatigable muscle weakness, including congenital myasthenic syndromes and the auto-immune disease myasthenia gravis. In addition to progressive muscle paralysis, the muscles that control swallowing and/or breathing can become weakened, leading to respiratory failure. Understanding the molecular basis of communication between nerves and muscles is therefore of key importance in defining how particular mutations can contribute to such pathological conditions. We have recently identified a novel intracellular signaling protein, ShcD that is expressed in skeletal muscle and participates in signaling pathways that ultimately control muscle contraction. We have now determined that ShcD can associate with additional cell surface receptors that may be important for development and differentiation of muscle cells at the NMJ. Using a combination of biochemical and cellular approaches, we propose to identify the molecular components and biological functions associated with ShcD in skeletal muscle cells and NMJs. The structure of this specialized synapse is under exquisite molecular control; thus, increasing our knowledge of the signaling mechanisms that contribute to the assembly and maintenance of the NMJ will provide further insight into how perturbations arise in diseases with altered neuromuscular transmission.
Competitiondate
201201
Approvedterm2
0 yr 3 mths
Pinamesdelim
Acai, Anita
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~